Andrew Morris

Vice President, Business Development CAMP4 Therapeutics

Seminars

Tuesday 28th April 2026
Effectively & Efficiently Structuring Deals as Small Neuroscience Companies
5:30 pm
  • Discussing the panel’s experience executing and performing due diligence across neuroscience deals – what are the learnings from having partnerships with pharma?
  • Discussing how to get proof of concept earlier to secure additional investment or partnership
  • Outlining opportunities for creative deal structures, and when and where they would be appropriate
Andrew Morris - 2nd Neuroscience Innovation Partnering & Licensing